Professor Glenda Gray is a scientist working around the clock to stem the impact of HIV-Aids in the country. Gray is a senior ...

GlobalData epidemiologists project TB cases across the 16 major markets to reach 4.5 million by 2033.

National Institutes of Health Director Dr. Jay Bhattacharya attempted to reassure members of Congress on both sides of the ...

RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production.

New research shows first population-level evidence globally that a national HPV vaccination program can be highly effective ...

People living with HIV represent a unique population in the field of infectious disease and immunology due to persistent immune dysregulation and an ...

The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical trial stages, the first COVID-19 mRNA vaccine was administered on 8 December ...

The HIV prevention shot lenacapavir will be rolled out at South African clinics within the next few months – from 2027, the ...

The Federal Government has confirmed the arrival of the long-acting HIV prevention injection, Lenacapavir, marking a major ...

In this special briefing, Spotlight unpacks what we do and do not know about asymptomatic TB. Tuberculosis (TB) is a ...

GSK is sourcing early-stage science across a wide range of technologies and disease areas, while placing more selective bets ...